Clinical Trials

Pharmaxis has conducted a number of clinical trials as part of the regulatory approvals process for Bronchitol.


No further clinical development is planned for bronchiectasis.

Phase II
Description B201 and B202: Proof of Concept
Sites Australia, New Zealand
Subjects 60
Status Complete
More Information


Media Releases is a service provided by the U.S. National Institutes of Health, Department of Health and Human Services, through its National Library of Medicine. provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions. Pharmaxis chooses to publish all Pivotal Trials on the website.

** Pubmed is a service of the U.S. National Library of Medicine and the National Institutes of Health.

*** No further clinical development planned in Bronchiectasis